Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials

Darren J. Creek, William N. Charman, Francis C.K. Chiu, Richard J. Prankerd, Yuxiang Dong, Jonathan L. Vennerstrom, Susan A. Charman

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

The reaction of spiro- and dispiro-1,2,4-trioxolane antimalarials with heme has been investigated to provide further insight into the mechanism of action for this important class of antimalarials. A series of trioxolanes with various antimalarial potencies was found to be unreactive in the presence of Fe(III) hemin, but all were rapidly degraded by reduced Fe(II) heme. The major reaction product from the heme-mediated degradation of biologically active trioxolanes was an alkylated heme adduct resulting from addition of a radical intermediate. Under standardized reaction conditions, a correlation (R2 = 0.88) was found between the extent of heme alkylation and in vitro antimalarial activity, suggesting that heme alkylation may be related to the mechanism of action for these trioxolanes. Significantly less heme alkylation was observed for the clinically utilized artemisinin derivatives compared to the equipotent trioxolanes included in this study.

Original languageEnglish (US)
Pages (from-to)1291-1296
Number of pages6
JournalAntimicrobial Agents and Chemotherapy
Volume52
Issue number4
DOIs
StatePublished - Apr 1 2008

Fingerprint

Antimalarials
Alkylation
Heme
Hemin

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials. / Creek, Darren J.; Charman, William N.; Chiu, Francis C.K.; Prankerd, Richard J.; Dong, Yuxiang; Vennerstrom, Jonathan L.; Charman, Susan A.

In: Antimicrobial Agents and Chemotherapy, Vol. 52, No. 4, 01.04.2008, p. 1291-1296.

Research output: Contribution to journalArticle

Creek, Darren J. ; Charman, William N. ; Chiu, Francis C.K. ; Prankerd, Richard J. ; Dong, Yuxiang ; Vennerstrom, Jonathan L. ; Charman, Susan A. / Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials. In: Antimicrobial Agents and Chemotherapy. 2008 ; Vol. 52, No. 4. pp. 1291-1296.
@article{fddd51d28b934cf2a8da200816445776,
title = "Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials",
abstract = "The reaction of spiro- and dispiro-1,2,4-trioxolane antimalarials with heme has been investigated to provide further insight into the mechanism of action for this important class of antimalarials. A series of trioxolanes with various antimalarial potencies was found to be unreactive in the presence of Fe(III) hemin, but all were rapidly degraded by reduced Fe(II) heme. The major reaction product from the heme-mediated degradation of biologically active trioxolanes was an alkylated heme adduct resulting from addition of a radical intermediate. Under standardized reaction conditions, a correlation (R2 = 0.88) was found between the extent of heme alkylation and in vitro antimalarial activity, suggesting that heme alkylation may be related to the mechanism of action for these trioxolanes. Significantly less heme alkylation was observed for the clinically utilized artemisinin derivatives compared to the equipotent trioxolanes included in this study.",
author = "Creek, {Darren J.} and Charman, {William N.} and Chiu, {Francis C.K.} and Prankerd, {Richard J.} and Yuxiang Dong and Vennerstrom, {Jonathan L.} and Charman, {Susan A.}",
year = "2008",
month = "4",
day = "1",
doi = "10.1128/AAC.01033-07",
language = "English (US)",
volume = "52",
pages = "1291--1296",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials

AU - Creek, Darren J.

AU - Charman, William N.

AU - Chiu, Francis C.K.

AU - Prankerd, Richard J.

AU - Dong, Yuxiang

AU - Vennerstrom, Jonathan L.

AU - Charman, Susan A.

PY - 2008/4/1

Y1 - 2008/4/1

N2 - The reaction of spiro- and dispiro-1,2,4-trioxolane antimalarials with heme has been investigated to provide further insight into the mechanism of action for this important class of antimalarials. A series of trioxolanes with various antimalarial potencies was found to be unreactive in the presence of Fe(III) hemin, but all were rapidly degraded by reduced Fe(II) heme. The major reaction product from the heme-mediated degradation of biologically active trioxolanes was an alkylated heme adduct resulting from addition of a radical intermediate. Under standardized reaction conditions, a correlation (R2 = 0.88) was found between the extent of heme alkylation and in vitro antimalarial activity, suggesting that heme alkylation may be related to the mechanism of action for these trioxolanes. Significantly less heme alkylation was observed for the clinically utilized artemisinin derivatives compared to the equipotent trioxolanes included in this study.

AB - The reaction of spiro- and dispiro-1,2,4-trioxolane antimalarials with heme has been investigated to provide further insight into the mechanism of action for this important class of antimalarials. A series of trioxolanes with various antimalarial potencies was found to be unreactive in the presence of Fe(III) hemin, but all were rapidly degraded by reduced Fe(II) heme. The major reaction product from the heme-mediated degradation of biologically active trioxolanes was an alkylated heme adduct resulting from addition of a radical intermediate. Under standardized reaction conditions, a correlation (R2 = 0.88) was found between the extent of heme alkylation and in vitro antimalarial activity, suggesting that heme alkylation may be related to the mechanism of action for these trioxolanes. Significantly less heme alkylation was observed for the clinically utilized artemisinin derivatives compared to the equipotent trioxolanes included in this study.

UR - http://www.scopus.com/inward/record.url?scp=42049102584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42049102584&partnerID=8YFLogxK

U2 - 10.1128/AAC.01033-07

DO - 10.1128/AAC.01033-07

M3 - Article

C2 - 18268087

AN - SCOPUS:42049102584

VL - 52

SP - 1291

EP - 1296

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 4

ER -